Δpep27 upregulated Tregs and increased the levels of anti-inflammatory transcripts (IL-10 in particular) in the VEET and VIVIT groups, suggesting that Δpep27 upregulated the Treg-dependent blockade of NFAT that can be an alternate therapeutic target in IBD [20]. This evidence concerns the gene IL10 and inflammatory bowel disease.